Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cholesterol Guideline Changes Double Number on Treatments
Bloomberg
Wednesday, November 13, 2013 - 8:48am
tags:
cholesterol, statins, AstraZeneca, Merck, Pfizer
[video]Bristol-Myers Squibb's Radical Transformation
Motley Fool
Wednesday, November 13, 2013 - 8:47am
tags:
Bristol-Myers Squibb
Alzheimer’s Clues Sought Studying Link to Down Syndrome
Bloomberg
Wednesday, November 13, 2013 - 8:44am
tags:
Downs Syndrome, JNJ, Alzheimer's disease
Pfizer finally acquires the @pfizer name on Twitter
PM Live
Wednesday, November 13, 2013 - 8:33am
tags:
Pfizer, twitter, social media
Pfizer, Lilly Vs. Rivals In Potential Pain Drug Rivalry
Seeking Alpha
Wednesday, November 13, 2013 - 8:32am
tags:
Pfizer, Eli Lilly, painkillers, tanezumab
Why Big Pharma Is Breaking Up
Motley Fool
Wednesday, November 13, 2013 - 8:29am
tags:
Merck, Novartis, Big Pharma, Abbott Labs, AbbVie, Pfizer, Zoetis
When Should You Take A Statin? The Answer Just Changed.
Forbes
Wednesday, November 13, 2013 - 8:26am
tags:
statins
Discovery Labs Reports Third Quarter 2013 Financial Results
Yahoo
Wednesday, November 13, 2013 - 8:25am
tags:
Discovery Labs, earnings
J&J Said to Reach $4 Billion Deal to Settle Hip Lawsuits
Bloomberg
Tuesday, November 12, 2013 - 4:55pm
tags:
JNJ, hip implants, devices, recalls, DePuy
J&J's Velcade gets stiff-armed at NICE as first-line myeloma treatment
Fierce Pharma
Tuesday, November 12, 2013 - 4:37pm
tags:
JNJ, Velcade, Multiple Myeloma
Actavis to shed 310 jobs in shutdown of NC plant
Fierce Pharma
Tuesday, November 12, 2013 - 4:34pm
tags:
Actavis, drug manufacturing, layoffs
What The Delay Of A Promising Muscular Dystrophy Drug Means For Patients, Investors And All Of Biotech
Forbes
Tuesday, November 12, 2013 - 4:32pm
tags:
Duchenne Muscular Dystrophy, eteplirsen, Sarepta Therapeutics
Medivation Reports Third Quarter Financial Results and Provides Corporate Update
Yahoo
Tuesday, November 12, 2013 - 4:28pm
tags:
Medivation, earnings
Is Arena Pharmaceuticals Making Progress?
Daily Finance
Tuesday, November 12, 2013 - 1:13pm
tags:
Arena Pharmaceuticals, Belviq, obesity, Eisai
Shire Acquires Viropharma: Two Winners In This Deal
Seeking Alpha
Tuesday, November 12, 2013 - 1:11pm
tags:
Shire, ViroPharma, M&A
Gilead Five-year Revenue Outlook, Part 1
Seeking Alpha
Tuesday, November 12, 2013 - 1:10pm
tags:
Gilead Sciences
Biogen’s Hemophilia Drug Delay May Push Sales to Mid-2014
Bloomberg
Tuesday, November 12, 2013 - 1:09pm
tags:
hemophilia, Biogen Idec, Eloctate
Ohr Pharma: A Pure 2014 Catalyst Play With Large Potential
Seeking Alpha
Tuesday, November 12, 2013 - 1:08pm
tags:
Ohr Pharmaceutical, wet-AMD, Squalamine Eye Drops, ovarian cancer
Endo Tax Edge for Deals Mimics Valeant Playbook: Real M&A
Bloomberg
Tuesday, November 12, 2013 - 11:04am
tags:
Endo Health Solutions, M&A, Valeant Pharmaceuticals
Will Galena Biopharma Triple Soon?
Wall St Cheat Sheet
Tuesday, November 12, 2013 - 10:06am
tags:
Galena Biopharma, Abstral

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.